Figures & data
Table 1 Prevalence of CD
Table 2 Market share and absolute number of patients receiving BoNT-A
Table 3 BoNT-A medication treatment cost and dosage
Table 4 Resource use for BoNT-A and best supportive care (without BoNT-A) arms in the base case
Table 5 BoNT-A medication dosage for “real-world” settings
Table 6 Net 5-year budget impact of increasing abobotulinumtoxinA market share compared to status quo assumptions in the treatment of cervical dystonia in the UK
Figure 1 Cost of BoNT-A and best supportive care per patient per year by cost component.
![Figure 1 Cost of BoNT-A and best supportive care per patient per year by cost component.](/cms/asset/416adb45-0a3d-498f-974b-477da6c4820e/dceo_a_86355_f0001_c.jpg)
Figure 2 Tornado diagram of one-way sensitivity analysis showing the parameters that are most influential on net budget impact.
![Figure 2 Tornado diagram of one-way sensitivity analysis showing the parameters that are most influential on net budget impact.](/cms/asset/95c34eb6-09e3-4f13-8762-d872a4203a58/dceo_a_86355_f0002_c.jpg)
Table 7 Variable description for tornado diagram